punterpk

SUNPHARMA CHECK

Formación
punterpk Actualizado   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
For the past several weeks, SUNPHARMA has been lodged inside a downward channel while NIFTY has tested new highs. Now within this channel it seems to have formed a highly bearish Head & Shoulders pattern whose height is measured at a mind boggling 245 points! I wonder what does the market know that we poor slobs are unaware of! Worth watching this stock's chart for education.
Comentarios:
Below 372 but Volume needs to catch up.
Comentarios:

As this hourly chart shows, any rise to 385 levels should be used to short it as the price is dipping below 372 although breakdown volume is not seen yet.
Comentarios:
The tussle between bulls & bears is on. The stock has turned quite volatile. Volumes are rising. Today is weekly expiry so this is expected. No entry in the stock at present.
Comentarios:
It's 10:50am and our stock has touched 384.50. High risk traders can enter shorts with a strict stop loss.
Comentarios:
11:45am After going below 380 it sprung back up to eat stop losses, touched 386.85. Rest of the day is going to be crucial whether bulls can maintain their lead. I doubt it.
Comentarios:
12:28am Touched 388.60. Bulls have turned vicious taking bears to the cleaners.
Comentarios:
On the back of FED's comment that they MAY consider cutting rates, global markets rallied, and so did Sunpharma to touch 392 level yesterday. But Daily volume was still average. On a weekly basis our analysis above still stands unless it breaks above 436-38 levels. It must be noted that brokerage houses like ICICIBANK, Sharekhan have a HOLD call with 460 as target (which is still well below the right shoulder top of 484 in H&S pattern.)
Comentarios:
Recent bullish push to 410 level notwithstanding, once again Sunpharma is dipping below 372 levels and easily breached recent low of 368. I still feel it's got downward bearish potential that remains untapped.
Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.